Epsilon M&A Deal Report - SDN (SDN Istituto di Ricerca Diagnostica e Nucleare)
Transaction Multiples for the Valuation of Private Companies
Labco / SDN (SDN Istituto di Ricerca Diagnostica e Nucleare)
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
Current |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
Date | Acquirer | Target | Country | Multiples | See details |
14/11/2014 | Recipharm | Lusomedicamenta-sociedade Tecnica Farmaceutica | Portugal | *** | 68626 |
06/10/2014 | Private Group led by Qualium Investissement | Aigle Capital (IMV Technologies) | France | ** | 68494 |
Source: Epsilon Research / EMAT